Versant Venture Management as of March 31, 2019
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 9 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 50.0 | $152M | 4.2M | 35.72 | |
| Veracyte (VCYT) | 29.8 | $91M | 3.6M | 25.02 | |
| Audentes Therapeutics | 10.3 | $31M | 803k | 39.02 | |
| Cymabay Therapeutics | 4.8 | $14M | 1.1M | 13.31 | |
| Ocular Therapeutix (OCUL) | 2.9 | $8.8M | 2.2M | 3.97 | |
| Second Sight Med Prods | 1.2 | $3.6M | 4.5M | 0.80 | |
| Clovis Oncology | 0.8 | $2.5M | 102k | 24.82 | |
| Achaogen | 0.2 | $585k | 1.3M | 0.46 | |
| Opgen | 0.0 | $62k | 102k | 0.60 |
